Natalizumab Reduces Visual Loss in Patients with Relapsing Multiple Sclerosis
Neurol 68:1299-1302, Balcer,L.J.,et al, 2007
A Randomized Controlled Study of the Acute and Chronic Effects of Cooling Therapy for MS
Neurol 60:1955-1960, NASA/MS Cooling Study Group, 2003
Looking Beyond the Usual
Delhi J Ophthal doi:7869/djo.555, Shakrawal, J.,et al, 2020
Longitudinal Study of Vision and Retinal Nerve Fiber Layer Thickness in Multiple Sclerosis
Ann Neurol 67:749-760, Talman,L.S., et al, 2010
NMO-IgG Predicts the Outcome of Recurrent Optic Neuritis
Neurol 70:2197-2200, Matiello,M.,et al, 2008
Clinical Characteristics of African Americans vs Caucasian Americans with Multiple Sclerosis
Neurol 63:2039-2045, Bree,B.A.C.,et al, 2004
Fomepizole for the Treatment of Methanol Poinsoning
NEJM 344:424-429, Brent,J.,et al, 2001
Optic Neuritis in African Americans
Arch Neurol 55:186-192, Phillips,P.H.,et al, 1998
Effects of Weight Loss on the Course of Idiopathic Intracranial Hypertension in women
Neurol 50:1094-1098, Kupersmith,M.J.,et al, 1998
Optic Nerve Sheath Fenestration for Pseudotumor Cerebri
J Neuro-Ophthalmol 17:86-91, Goh,K.Y.,et al, 1997
Visual Morbidity in Giant Cell Arteritis:Clinical Characteristics and Prognosis for Vision
Ophthalmology 101:1779-1785, Liu,G.T.,et al, 1994
Lidocaine Unmasks Silent Demyelinative Lesions in Multiple Sclerosis
Neurol 42:2088-2093, Sakurai,M.,et al, 1992
A Simple Procedure for General Screening for Functional Disability in Elderly Patients
Ann Int Med 112:699-706, Lachs,M.S.,et al, 1990
Visual Improvement with SMS 201-995 in a Patient with a Thyrotropin-Secreting Pituitary Adenoma
NEJM 317:53-54, Guillaussea,P.J.,et al, 1987
Improvement in Multiple Sclerosis during Prolonged Induced Hypothermia
Neurol 27:302, Symington,G.R.,et al, 1977